Welcome to our dedicated page for Tabula Rasa Heal news (Ticker: TRHC), a resource for investors and traders seeking the latest updates and insights on Tabula Rasa Heal stock.
Tabula Rasa HealthCare, Inc. (TRHC) generates news that reflects its focus on medication safety, pharmacy services and technology-enabled solutions for value-based care organizations. Company announcements highlight how TRHC works with health plans, at-risk provider groups and programs such as the Program of All-Inclusive Care for the Elderly (PACE) to address medication-related risks and support complex patient populations.
News coverage for TRHC often includes financial results and operational updates. Earnings releases describe trends in medication revenue and technology-enabled solutions revenue, with commentary on factors such as PACE census growth, revenue per PACE participant and changes in gross margin. These updates also discuss non-GAAP measures like adjusted EBITDA, adjusted gross profit and adjusted operating income or loss, which TRHC presents as supplemental indicators of performance.
Another key category of TRHC news involves strategic and corporate developments. The company has reported the divestiture of non-core businesses such as SinfoníaRx and DoseMe, and it announced a definitive agreement to be acquired by Nautic Partners and combined with ExactCare Pharmacy. Corporate updates have also covered leadership changes, including the appointment of a new President and Chief Executive Officer and the addition of a Chief Legal Officer and Corporate Secretary.
TRHC also issues news about client relationships and solution deployments. For example, the company announced that Mountain Empire PACE signed agreements for personalized pharmacy services and pharmacy benefit management, building on existing use of PACElogic integrated technology solutions and PeakTPA administration services. Such stories illustrate how TRHC’s offerings are applied in real-world care settings.
Investors, analysts and healthcare professionals can use this news stream to follow TRHC’s financial performance, corporate actions, partnerships and the evolution of its medication safety and pharmacy care solutions over time.
Tabula Rasa HealthCare (NASDAQ: TRHC) will discuss its first quarter 2021 operating results in a conference call on May 7, 2021, at 8:30 a.m. EDT. Financial results will be released after market close on May 6, 2021. The call will feature CEO Calvin H. Knowlton, Co-Founder Orsula V. Knowlton, and CFO Brian W. Adams. Investors can access the webcast via TRHC's investor relations website. A replay will be available for 7 days following the call, and an audio archive will be accessible for 90 days.
Tabula Rasa HealthCare (TRHC) has partnered with OneOme, co-founded by Mayo Clinic, to enhance pharmacogenomics (PGx) implementation in healthcare. This collaboration combines OneOme's RightMed® Test with TRHC's MedWise® technology, aiming to optimize patient medication regimens by analyzing gene variations and external factors affecting drug response. The partnership is expected to improve patient outcomes and reduce adverse drug events, providing significant value to patients, providers, and payors.
Tabula Rasa HealthCare (TRHC) has expanded its COVID-19 services for pharmacies, enhancing patient engagement solutions to support vaccine administration. With the launch of contact-free vaccination management through its PrescribeWellness platform, pharmacies can streamline vaccine intake and scheduling. The Federal Retail Pharmacy Program now includes community pharmacists as key vaccine providers, necessitating TRHC's continued support. TRHC's tele-pharmacy services, staffed by over 800 professionals, ensure vaccine education and appointment management while adhering to strict privacy regulations.
Tabula Rasa HealthCare, Inc. (TRHC) has partnered with athenahealth to integrate its MedWise® technology into the athenahealth Marketplace. This technology enhances medication safety by identifying multi-drug interactions, improving treatment adherence, and ultimately lowering healthcare costs. The MedWise Risk Score will now be accessible to healthcare providers at the point of prescribing, aiding in risk management and medication optimization. This partnership aims to enhance medication outcomes and reduce total medical spending across athenahealth's extensive provider network.
Tabula Rasa HealthCare (TRHC) announces a new study published in the Journal of Patient Safety, demonstrating that higher Medication Risk Scores (MRS) correlate with increased mortality risks. Conducted using EHR data from over 427,000 patients, the study highlights the MedWise Risk Score as a significant predictor of adverse drug events (ADEs). This innovative model emphasizes the need for clinical pharmacy interventions for patients with elevated MRS, particularly those aged 30-49 with MRS ≥20, to enhance medication safety and reduce hospitalizations.
Tabula Rasa HealthCare (TRHC) has partnered with Infectious Disease Connect to integrate its precision dosing solution, DoseMeRx, into ID Connect's software, ILÚM Insight. This collaboration aims to provide real-time access to personalized dosing for antimicrobials, enhancing patient safety and optimizing pharmacy workflows. TRHC's technology supports healthcare providers in individualizing medication dosing, ultimately improving patient outcomes and reducing clinician workload. The partnership aligns with both companies' missions to enhance healthcare delivery.
Summary not available.
Tabula Rasa HealthCare (TRHC) supports New Jersey legislation to create a medication risk reduction model for the state's Medicaid program. CEO Calvin Knowlton highlighted that this model aligns with TRHC's Enhanced Medication Therapy Management (EMTM) approach, aiming to minimize adverse drug events (ADEs). The legislation, unanimously approved by both the NJ Senate and Assembly Human Services Committee, is backed by Governor Phil Murphy. TRHC's MedWise technology has demonstrated effectiveness in reducing ADEs and associated healthcare costs, reflecting the company's commitment to improving medication safety.
On March 10, 2021, Tabula Rasa HealthCare (NASDAQ: TRHC) announced a partnership with eight state pharmacy associations to promote its medication safety software, MedWise™. This initiative aims to educate pharmacists on enhancing patient outcomes and reducing costs by becoming Certified MedWise Advisors™. MedWise helps identify multi-drug interactions and improve medication management, contributing to safer healthcare practices. TRHC's software is positioned as a significant advancement in pharmacy care, with plans to expand its reach across the U.S.
Tabula Rasa HealthCare (TRHC) announced significant milestones in March 2021, achieving its highest-ever PACE census enrollment and a record net enrollment month. This rebound follows a COVID-19-related decline from spring 2020, boosted by vaccination efforts. The company also implemented new pharmacy clients and expanded services for existing ones, contributing to future revenue growth. Currently, 28 new PACE centers are contracted to open, projected to generate about $50 million in annual revenue at full capacity.